Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2003
10/02/2003WO2002054872A8 Liquid antimicrobial compositions
10/02/2003WO2002042432A3 Epothilone resistant cell lines
10/02/2003WO2002022809A3 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002020570A3 Mitochondrial membrane permeabilization bv hiv-1 vpr and methods of screening
10/02/2003WO2002005782A3 Stable salts of o-acetylsalicyclic with basic amino acids
10/02/2003WO2001098508A3 Transgenic mice containing targeted gene disruptions
10/02/2003WO2001098491A3 Osteolevin gene polymorphisms
10/02/2003US20030187200 Comprises nucleotide sequences coding kunitz-type protease inhibitor for treating reproductive, hemostatic and inflammatory disorders
10/02/2003US20030187070 Ibuprofen solutions for capsule-filling and capsule preparations
10/02/2003US20030187055 Synergistic pharmaceutical combinations for treating obesity
10/02/2003US20030187052 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders
10/02/2003US20030187034 Composition containing at least one aryl oxime and at least one active substance for treating acne and the use thereof
10/02/2003US20030187033 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents
10/02/2003US20030187028 Synergistic mixtures; side effect reduction
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187006 Method for enhancing cognitive function
10/02/2003US20030187003 Synergistic mixture of pyrano(2,3-d:6,5-d')dupyrimidine compound and viricide
10/02/2003US20030186994 Anticholesterol agents; cardiovascular disorders
10/02/2003US20030186992 Remedial agent for anxiety neurosis or depression and piperazine derivative
10/02/2003US20030186990 Prodrugs of hiv replication inhibiting pyrimidines
10/02/2003US20030186989 Antihistamines; respiratory system disorders
10/02/2003US20030186983 C-5 Modified indazolylpyrrolotriazines
10/02/2003US20030186978 Novel telomerase inhibitors
10/02/2003US20030186977 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
10/02/2003US20030186960 Nervous system regeneration
10/02/2003US20030186952 Anticholesterol agents; cardiovascular disorders
10/02/2003US20030186933 Preparation of aqueous clear solution dosage forms with bile acids
10/02/2003US20030186931 Comprises trehalose; for treatment of Gougerot-Sjogren Syndrome
10/02/2003US20030186926 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
10/02/2003US20030186925 Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives
10/02/2003US20030186906 Mixture comprising an inhibitor or suppresor of a gene and a molecule binding to an expression product of that gene
10/02/2003US20030186905 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone3' -untranslated region
10/02/2003US20030186897 Derivatives of branched-chain lipophilic molecules and uses thereof
10/02/2003US20030186896 Crystalline form of perindopril tert-butylamine salt
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186890 Amphipathic linear peptides and formulations containing said peptides
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186880 Combination therapy using trefoil peptides
10/02/2003US20030186877 Helical peptidomimetics
10/02/2003US20030186875 Uses of mammalian cytokine; related reagents
10/02/2003US20030186871 Contacting a solution comprising an AKR1C polypeptide or fragment with agent, selecting an agent that modulates the expression or catalytic activity of AKR1C polypeptide or fragmet, thereby identifying an agent for therapy of diabetes
10/02/2003US20030186870 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
10/02/2003US20030186845 Compositions for preventing urinary calculus
10/02/2003US20030186838 Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
10/02/2003US20030186424 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186415 Mutant possessing uracil phosphoribosyl transferase activity
10/02/2003US20030186381 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/02/2003US20030186370 Comprises nucleotide sequences coding nicotinic-acetylcholine receptor (5-ht3) for use in screening nematocides, insecticides and/or pesticides
10/02/2003US20030186369 Egg specific surface proteins
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186333 Comprises nervous system polypeptide for diagnosis, prognosis, treatment and evaluation of neurodegenerative disorders
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186305 Novel proteins
10/02/2003US20030186264 Comprises enzymatic polypeptide for diagnosis and treatment of genetic disorders; drug screening; immunoassay; high throughput assay
10/02/2003US20030186191 Dispensing apparatus and cartridge
10/02/2003US20030185917 Synergistic pharmaceutical composition for diabetic nephropathy
10/02/2003US20030185910 Cancer preventive composition comprising ginsenoside glycosides of red ginseng
10/02/2003US20030185888 Volume efficient controlled release dosage form
10/02/2003US20030185882 Pharmaceutical compositions containing oxybutynin
10/02/2003US20030185880 Glyburidge composition
10/02/2003US20030185879 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
10/02/2003US20030185873 Provides reversible local anesthesia when implanted or injected in a patient, and a non-glucocorticoid augmenting agent effective to prolong the duration of the local anesthesia
10/02/2003US20030185869 Having lysozyme adsorbed onto or associated with the surface of an active agent
10/02/2003US20030185860 Administering directly to a blood vessel
10/02/2003US20030185838 Administration of intestinal trefoil peptides.
10/02/2003US20030185834 Administering an anti-angiogenesis factor to localize in the choroidal neovasculature; administering photosensitizer; photodynamic therapy by irradiating with laser light
10/02/2003US20030185831 Methods of treating cancer using an FPT inhibitor and antineoplastic
10/02/2003US20030185824 Administering an inhibitor of the CD2/LFA-3 interaction, in combination with an auxiliary agent, such as UV-B
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185800 Human interferon-epsilon: a type I interferon
10/02/2003CA2761440A1 Fredericamycin derivatives
10/02/2003CA2756798A1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/02/2003CA2484044A1 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003CA2480335A1 Combined use of antitumor indolopyrrolocarbazole derivative and other antitumor agent
10/02/2003CA2480302A1 Compositions and methods for treating and preventing necrosis
10/02/2003CA2480032A1 Use of ltb4 antagonists in veterinary medicine
10/02/2003CA2479880A1 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer
10/02/2003CA2479731A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003CA2479730A1 Novel compositions and methods in cancer
10/02/2003CA2479727A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003CA2479723A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003CA2479722A1 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003CA2479721A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003CA2479718A1 Analgesics for nasal administration
10/02/2003CA2479671A1 Combination of an aldosterone receptor antagonist and nicotinic acid for a nicotinic acid derivative
10/02/2003CA2479555A1 Use of cocoa flavanols and oligomers thereof to treat cognitive dysfunction and improve cognitive function in neuro-compromised patients
10/02/2003CA2479338A1 Substituted phenylacetic acids
10/02/2003CA2479259A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
10/02/2003CA2479254A1 Preventive or therapeutic agent for renal disease
10/02/2003CA2478974A1 Inhalable sustained therapeutic formulations
10/02/2003CA2478855A1 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
10/02/2003CA2478330A1 Intraductal management of breast lesions involving therapeutic or diagnostic agents
10/02/2003CA2477812A1 A non-selective cation channel in neural cells and methods for treating brain swelling
10/02/2003CA2477088A1 Active agent delivery systems and methods for protecting and administering active agents
10/02/2003CA2476327A1 Method of administering an injectable antibiotic to the ear of an animal
10/01/2003EP1348443A1 Combination drugs
10/01/2003EP1348441A1 Topical anti-cancer compositions
10/01/2003EP1348427A1 Ophthalmic compositions containing galactomannan polymers and borate
1 ... 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 ... 1151